Bicycle Therapeutics (BCYC)CFO sold ~$282
Travis Alvin Thompson, CFO at Bicycle Therapeutics, sold ~$282 of Bicycle Therapeutics shares.
- ~$282
- Approx. value · 79 sh @ $3.57
- 64K
- Holds after · shares reported
- Traded
- Oct 5, 2026
- Filed
- Oct 7, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 18, 2026, Charles Swanton resigned as a Class II director of the Board of Directors (the “Board”) of Bicycle Therapeutics plc (the “Company”), as a member of the Board’s committees and as a member of the Company’s Clinical Advisory Board, effective immediately.”
- Oct 2, 2026Insider · 5 peopleInsiders: 5 sales (~$49K)
- Oct 5, 2026 · this disclosureInsiderCFO sold ~$282 of BCYC shares in the open market
What came next
- Oct 5, 2026Insider · 4 peopleInsiders: 5 sales (~$10K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Bicycle Therapeutics
For Bicycle Therapeutics, OQRO holds 12 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BCYC page.
Other recent filings by Travis Alvin Thompson, Chief Financial Officer
- SEC Form 4 at Bicycle Therapeutics (BCYC)Oct 7, 2026
- SEC Form 4 at Bicycle Therapeutics (BCYC)Jul 7, 2025
- SEC Form 4 at Bicycle Therapeutics (BCYC)Jul 7, 2025
- SEC Form 4 at Bicycle Therapeutics (BCYC)Apr 4, 2025
- SEC Form 4 at Bicycle Therapeutics (BCYC)Apr 4, 2025
The full history of Travis Alvin Thompson, Chief Financial Officer is on the profile page.
How this filing works
Other disclosures at Bicycle Therapeutics
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 7, 2026
- SEC Form 4Oct 7, 2026
Everything OQRO holds on this company is on its BCYC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
